<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03715231</url>
  </required_header>
  <id_info>
    <org_study_id>18-00429</org_study_id>
    <nct_id>NCT03715231</nct_id>
  </id_info>
  <brief_title>NIDEK Gonioscope GS-1 for Glaucoma</brief_title>
  <official_title>NIDEK Gonioscope GS-1 for Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Gonioscope GS-1 is an ophthalmic camera with gonioscopic prism that is intended to
      capture, display and store images of the anterior chamber angle and its peripheral part. This
      study evaluates the efficiency of Gonioscope GS-1 in glaucoma patients.With the captured
      images, the glaucoma diagnosis and post-operative observation are enabled.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 12, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inter-Observer Repeatability for NIDEK Gonioscope GS-1</measure>
    <time_frame>1 Day</time_frame>
    <description>To determine reliability, two observers will examine images from NIDEK Gonioscopes GS-1. Repeatability will mean observations of both observers will coincide.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inter-Observer Repeatability for Standard Digital Gonioscopic images</measure>
    <time_frame>1 Day</time_frame>
    <description>To determine reliability, two observers will examine images from NIDEK Gonioscopes GS-1. Repeatability will mean observations of both observers will coincide.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Glaucoma &amp; Glaucoma Suspect Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with Glaucomatous optic neuropathy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>NIDEK Gonioscope GS-1</intervention_name>
    <description>To determine inter-observer repeatability when using this device, two observers will examine each image obtained from NIDEK Gonioscope GS-1 and separately determine the iridocorneal angle. Inter-observer repeatability will be tested using Pearson correlation.</description>
    <arm_group_label>Glaucoma &amp; Glaucoma Suspect Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Standard Digital Gonioscopic Images</intervention_name>
    <description>To determine inter-observer repeatability when using this device, two observers will examine each image obtained from NIDEK Gonioscope GS-1 and separately determine the iridocorneal angle. Inter-observer repeatability will be tested using Pearson correlation.</description>
    <arm_group_label>Glaucoma &amp; Glaucoma Suspect Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with glaucoma or glaucoma suspect

        Glaucoma Suspect

          -  Glaucomatous optic neuropathy as described in the glaucoma patients below

          -  AND/OR ocular hypertension (IOP &gt; 21 mm Hg)

          -  Normal visual field

        Glaucoma Patients

          -  Clinical characteristics of glaucoma: ONH abnormalities: global rim thinning, rim
             notch, or disc hemorrhage; RNFL defect

          -  Typical glaucomatous field loss in reliable VF, reproducible glaucoma hemifield tests
             labeled outside normal limits on at least two consecutive tests.

          -  Both eyes will be included, except in cases where only one eye meets study criteria

        Exclusion Criteria:

          -  Corneal opacities (scars, edema, etc.)

          -  Pregnant or planning to become pregnant

          -  Inability to fixate gaze
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Schuman</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYUMC Langone</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tonya Robin</last_name>
    <phone>929 455 5041</phone>
    <email>tonya.robin@nyumc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tonya Robin</last_name>
      <phone>929-455-5041</phone>
      <email>tonya.robin@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Joel Schuman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 19, 2018</study_first_submitted>
  <study_first_submitted_qc>October 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2018</study_first_posted>
  <last_update_submitted>December 20, 2019</last_update_submitted>
  <last_update_submitted_qc>December 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). To achieve aims in the approved proposal.Investigators whose proposed use of the data has been approved by an independent review committee (&quot;learned intermediary&quot;) identified for this purpose.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Beginning 3 months and ending 5 years following article publication.</ipd_time_frame>
    <ipd_access_criteria>Requests should be directed to Zena.Moore@nyulangone.org to gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

